The sequencing phase of the human genome project is now near completion, but then what? An even harder challenge remains — to identify the structures and functions of all proteins encoded in the ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Adults with house dust mite allergy may lose allergen-specific antibodies over time, and this decline is associated with ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...